Nottingham Prognostic Index Plus: Validation of a clinical decision making tool in breast cancer in an independent series

The Nottingham Prognostic Index Plus (NPI+) is a clinical decision making tool in breast cancer (BC) that aims to provide improved patient outcome stratification superior to the traditional NPI. This study aimed to validate the NPI+ in an independent series of BC. Eight hundred and eighty five prima...

Descripción completa

Detalles Bibliográficos
Autores principales: Green, Andrew R, Soria, Daniele, Stephen, Jacqueline, Powe, Desmond G, Nolan, Christopher C, Kunkler, Ian, Thomas, Jeremy, Kerr, Gillian R, Jack, Wilma, Cameron, David, Piper, Tammy, Ball, Graham R, Garibaldi, Jonathan M, Rakha, Emad A, Bartlett, John MS, Ellis, Ian O
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858129/
https://www.ncbi.nlm.nih.gov/pubmed/27499914
http://dx.doi.org/10.1002/cjp2.32

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858129/
https://www.ncbi.nlm.nih.gov/pubmed/27499914
http://dx.doi.org/10.1002/cjp2.32

Ejemplares similares